Eli Lilly and Company announced its generic, half-priced version of Humalog insulin is now available for order in pharmacies across the U.S.
The Insulin Lispro Injection was the company’s response to mounting pressure to offer people who use Lilly’s rapid-acting insulin a lower-cost option.
Lilly’s Insulin Lispro Injection has a 50 percent lower list price than its identical medicine, Humalog® U-100 (insulin lispro injection) and is available in both a vial and KwikPen®.
Because they are the same insulin, pharmacists will be able to substitute Insulin Lispro Injection for Humalog.
In March, Lilly announced plans to introduce Insulin Lispro Injection, which fills another gap in the healthcare system. The people who are most likely to benefit from Insulin Lispro Injection are Medicare Part D beneficiaries, people with high-deductible health plans and the uninsured who use Humalog.
“The availability of Lilly’s Insulin Lispro Injection is important progress that helps more people afford their insulin,” said Mike Mason, senior vice president, Connected Care, and Insulins. “Lilly will continue to work with health plans, wholesalers, employers, and the government to work toward permanent solutions that will help every person with diabetes afford their medicines.”
Insulin Lispro Injection has a list price of $137.35 per vial and $265.20 for a package of five KwikPens. In addition to wholesaler contracts that have been secured, Lilly is working with payers to gain broad insurance coverage for Insulin Lispro Injection.
People with additional questions can also contact the Lilly Diabetes Solution Center at (833) 808-1234 from 9 am to 8 pm EST Monday through Friday to speak with a live representative.
“The current healthcare system isn’t working for everyone, causing a growing number of people with chronic conditions to struggle to afford their medicine,” Mason added. “But even one person with diabetes who can’t afford insulin is too many, which is why we introduced Insulin Lispro Injection. It adds to our suite of solutions that help significantly lower the amount people pay until a more sustainable solution is achieved.”
- Eli Lilly and Company. Lilly’s Lower-Priced Insulin Now Available. PR Newswire. (2019, May 22). Retrieved: https://www.prnewswire.com/news-releases/lillys-lower-priced-insulin-now-available-300854307.html